Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2010
12/07/2010US7845348 Methods for treating trigeminal neuralgia
12/07/2010US7845347 Methods for treating headaches
12/07/2010US7845346 Spray device
12/07/2010CA2616449C Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
12/07/2010CA2440111C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2381802C Synergistic combination of roflumilast and salmeterol
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138600A2 Pharmaceutical compositions for the treatment of pain
12/02/2010WO2010137689A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/02/2010WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component
12/02/2010WO2010136872A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
12/02/2010WO2010136803A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010WO2010136705A1 Pharmaceutical antitumor composition including a cdk inhibitor and a cell-growth inhibitor
12/02/2010WO2010136394A1 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
12/02/2010WO2010136153A1 A therapeutic combination comprising a pulmonary surfactant and a steroid
12/02/2010WO2010120695A3 5-ht4 receptor agonist compounds for treatment of cognitive disorders
12/02/2010WO2010115741A3 New therapeutic approaches for treating neuroinflammatory conditions
12/02/2010WO2010093789A3 A composition comprising (-) -trans-3- (5, 6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-l-yl)-4-(lh-indol-3-yl) pyrrolidine- 2, 5-dione in combination with a second anti-proliferative agent
12/02/2010WO2010057295A9 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
12/02/2010WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/02/2010WO2010049182A3 Treatment of retroviral reservoirs exploiting oxidative stress
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100305178 Pharmaceutical Composition
12/02/2010US20100305151 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100304484 Use of Alginate Matrices to Control Cell Growth
12/02/2010US20100303929 Compounds and methods for treating cancer
12/02/2010US20100303912 Nanocell Drug Delivery System
12/02/2010US20100303825 Anti-estrogen and immune modulator combinations for treating breast cancer
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303784 Preparation for the prevention and/or treatment of vascular disorders
12/02/2010CA2763402A1 A therapeutic combination comprising a pulmonary surfactant and a steroid
12/02/2010CA2763275A1 Continuous administration of integrin ligands for treating cancer
12/02/2010CA2763172A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010CA2762528A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2255848A2 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
12/01/2010EP2255830A1 Concomitant drug
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis
12/01/2010EP2255784A1 Composition for easing human childbirth
12/01/2010EP2255184A2 Serotonin transporter gene and treatment of alcoholism
12/01/2010EP2254603A2 Methods for inhibiting six 1 and eya proteins
12/01/2010EP2254602A2 Continuous cell programming devices
12/01/2010EP2254599A2 Combination of an iron chelator and an immunosuppressant and use thereof
12/01/2010EP2254598A2 Alpha 7 nicotinic agonists and antipsychotics
12/01/2010EP2254573A1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
12/01/2010EP2254571A2 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
12/01/2010EP2254570A1 Combination comprising paclitaxel for treating ovarian cancer
12/01/2010EP2254563A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
12/01/2010EP2040689B1 Solution comprising n-acetylcysteine and gluconic acid, and methods to reduce, treat and/or prevent oxidative stress and cell activation
12/01/2010EP1926483B1 Treatment of autoimmune diseases
12/01/2010EP1423425B1 Receptor, the use thereof, and mouse antibodies
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010EP1284137B1 Nonoral preparation having three-layer structure
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1913896B Methods and compositions for the treatment and management of hemoglobinopathy and anemia
12/01/2010CN1902307B Tissue regeneration method
12/01/2010CN101903403A CD19 binding agents and uses thereof
12/01/2010CN101903045A Pharmaceutical composition for treatment of cataract
12/01/2010CN101897973A Application of pharmaceutical composition containing calcium antagonists and B vitamins to preparing medicines for treating peripheral arterial diseases
12/01/2010CN101897972A Application of pharmaceutical composition containing ACEI and B vitamins in preparing medicine for treating peripheral artery diseases
12/01/2010CN101897971A Application of medicine composition containing ARB-group and B-group vitamins in preparing medicament for treating peripheral artery diseases
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897969A Use of complement inhibitors in preparing medicines for preventing or treating tissure damage
12/01/2010CN101897968A Compound preparation for treating dyslipidemia
12/01/2010CN101897967A Seabuckthorn flavone compound preparation for treating dyslipidemia
12/01/2010CN101897735A Ginkgo flavone complex preparation for treating dyslipidemia
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897711A Pharmaceutical composition containing HMG-CoA reductase inhibitor, aspirin, folic acid and nicotinic acid and applications thereof
12/01/2010CN101897704A Compositions containing alpha-2-adrenergic agonist components
12/01/2010CN101897697A Sugar-lowering drug composition and application
12/01/2010CN101897696A Sugar-lowering drug composition and application thereof
12/01/2010CN101342142B Temperature sensing in situ gel rubber formulations capable of being injected, preparation method and uses thereof
12/01/2010CN101293073B Chinese medicinal composition for treating systematic lupus erythematosus
12/01/2010CN101069746B Composition containing sugar-reducing medicine and antiplatelet medicine
12/01/2010CN101002758B Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/2010
11/30/2010US7842791 Dispersible pharmaceutical compositions
11/30/2010US7842722 contain cobeadlets comprising vitamin E and carotenoids in the form of Vitamin A, lutein and/or zeaxanthing; further contain Vitamin C, copper and zinc; improving ocular nutrition
11/30/2010US7842719 Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
11/30/2010US7842706 Pharmaceutical composition
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842683 Beta-lactam antibiotics and beta-lactamase inhibitors provide significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and antiaggressive behavior modification and enhanced cognition
11/30/2010US7842678 Compositions comprising oligosaccharides
11/30/2010US7842311 for oral dosage; for treatment of pain; sustained release
11/30/2010US7842309 Tamper-resistant oral opioid agonist formulations
11/30/2010CA2473038C Weight management system for obese animals
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2412804C Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
11/30/2010CA2396129C Method and formulation for treating resistance to antihypertensives and related conditions
11/30/2010CA2315693C Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/25/2010WO2010135470A1 Pifenidone derivatives for treating bronchial asthma
11/25/2010WO2010135242A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy
11/25/2010WO2010134433A1 Transdermal preparation
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1151